HA/PEI and HA/PEG nanoparticles were used to deliver multidrug resistance 1 (MDR1) siRNA in CD44+ ovarian cancer cells in combination with PTX, resulting in MDR1 downregulation, increasing apoptosis and the suppression of ovarian cancer growth [227]. This evidence concerns the gene CD44 and ovarian cancer.